Through one mechanism, inactivating mutations of DKC1 in dyskeratosis congenital cause the lack of pseudouridylation of rRNA, thus leading to dysfunctional translation and cancer progression [214, 215] (Table 1). This evidence concerns the gene DKC1 and cancer.